Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

J.W. Jacobeit; L.J.G. Gooren; H.M. Schulte

doi:10.1530/EJE-09-0412

Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

J.W. Jacobeit
, L.J.G. Gooren
, H.M. Schulte

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	795-798
Journal	European Journal of Endocrinology
Volume	161
Issue number	5
DOIs	https://doi.org/10.1530/EJE-09-0412
Publication status	Published - 2009

Access to Document

10.1530/EJE-09-0412

Cite this

@article{86f11873747f440199d5fc596c7f05c2,

title = "Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals",

author = "J.W. Jacobeit and L.J.G. Gooren and H.M. Schulte",

year = "2009",

doi = "10.1530/EJE-09-0412",

language = "Undefined/Unknown",

volume = "161",

pages = "795--798",

journal = "European Journal of Endocrinology",

issn = "0804-4643",

publisher = "BioScientifica Ltd.",

number = "5",

}

TY - JOUR

T1 - Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

AU - Jacobeit, J.W.

AU - Gooren, L.J.G.

AU - Schulte, H.M.

PY - 2009

Y1 - 2009

U2 - 10.1530/EJE-09-0412

DO - 10.1530/EJE-09-0412

M3 - Article

C2 - 19749027

SN - 0804-4643

VL - 161

SP - 795

EP - 798

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

IS - 5

ER -